Haemonetics (HAE) Misses Q4 EPS by 21c, Revenues Beat; Offers FY22 EPS Guidance Above Consensus
Go back to Haemonetics (HAE) Misses Q4 EPS by 21c, Revenues Beat; Offers FY22 EPS Guidance Above Consensus| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 108.73 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.73 | 52 Week High | $39.41 | |||
| Open | $108.73 | 52 Week Low | $25.98 | |||
| Day High | $108.73 | P/E | 153.14 | |||
| Day Low | $108.73 | EPS | $0.71 | |||
| Volume | 3,451 | |||||
